UMB Financial Corp SEC Filings

Stacy H. King, Chief Risk Officer and director of UMB Financial Corp, reported insider transactions on 08/22/2025. The Form 4 shows two open-market sales of common stock: 100 shares sold at $118.69 and 1,400 shares sold at $118.89. Following these disposals, Ms. King directly beneficially owned 9,472 shares (down from 10,872 prior to the sales) and held an indirect interest of 52.383 shares via an ESOP. The filing was signed by attorney-in-fact Jason D. Bartel on 08/22/2025.

Form 144 notice for UMB Financial (UMBFP) records a proposed sale of common stock under Rule 144. The filer plans to sell 1,500 common shares08/22/2025 with an aggregate market value of $178,315.00. The filing shows 75,928,255 shares outstanding, and the 1,500 shares represent approximately 0.002% of outstanding common stock. The securities to be sold were acquired through restricted stock vesting in January and February 2025 (multiple vesting dates totaling the reported units). The filer certifies there are no undisclosed material adverse facts and reports no securities sold in the past three months for the account. The notice includes broker information and acquisition dates for each vested grant.

UMB Financial Corp insider sale by Chairman & CEO: The Form 4 shows Kemper J. Mariner, who is Chairman and CEO and a director, sold 15,523 shares of UMB Financial common stock on 08/13/2025 at a weighted-average price of $116.3269 per share. After the reported sales, the filing lists total beneficial ownership of 1,536,781 shares across direct and multiple indirect holdings (trusts, family custodial accounts, ESOP, and affiliated entities). The price represents a weighted average from multiple transactions between $116.20 and $116.75. The form was signed by Megan Mercer as attorney-in-fact for Mr. Mariner.

UMB Financial Corp insider sale by Chief Human Resource Officer Robert Brian Beaird sold 1,205 shares of UMB Financial Corp common stock on 08/13/2025 at a weighted average price of $116.17 per share. After the sale, Mr. Beaird beneficially owned 10,147.3509 shares directly and 216.0408 shares indirectly through an ESOP. The filing was signed by an attorney-in-fact on 08/14/2025. The form notes the sale occurred in multiple transactions at prices ranging from $116.17 to $116.20 and offers to provide further breakdown on request.

UMB Financial Corporation (Form 144) shows a proposed sale of 1,205 common shares through Merrill Lynch with an aggregate market value of $139,986.00. The filing lists 48,530,798 shares outstanding and an approximate sale date of 08/13/2025 on NASDAQ. The shares were acquired via restricted stock vesting on 01/29/2024 from UMB Financial and the filing reports no securities sold in the past three months.

The filing omits specific filer identification details in the visible content; it includes the required representation that the person signing does not possess undisclosed material adverse information and notes the sale is subject to Rule 144 conditions. The transaction appears to be a routine disposition of vested restricted shares rather than an extraordinary corporate event.

UMB Financial Corporation (UMBFP) filed a Form 144 reporting a proposed sale of 15,523 shares of common stock, with an aggregate market value of $1,796,477.00, to be sold on 08/13/2025 on NASDAQ. The filing shows 75,928,255 shares outstanding, so the proposed sale represents approximately 0.02% of outstanding shares.

The shares to be sold were recorded as acquired on 01/02/2014 through a Successor Trust from R.C. Kemper, Jr.; the donor acquisition date is listed as 01/05/1970 and an earlier amount recorded is 2,161,386 shares. The notice also lists multiple related-party sales during June–August 2025 by charitable trusts and affiliated entities, each showing share amounts and gross proceeds, indicating continuing disposals of holdings by those trusts.